Delivery Order SPE2DB20D1100-SPE2DB24FD6T6

Award Date 9/6/24
Potential Completion Date 9/9/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of glycopyrrolate 1 mg/5 ml vials, a medication used to treat certain medical conditions. The contract is a firm fixed-price delivery order with a ceiling value of $2,172.95 and a completion date of March 21, 2025. The contract is not designated as a set-aside....
This contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of 4,565,051,048 units of the pharmaceutical product glycopyrrolate 1ML 25S. The contract has a ceiling value of $3,368.70 and is a firm fixed-price delivery order. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,910.85 firm fixed-price contract is for the supply of GLYCOPYRROLATE 0.2 MG/ML medication, a critical pharmaceutical product used in medical treatment. The contract has an ultimate completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, SPE2DB20D7059|SPE2DB25FPWL4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,495.04 fixed-price delivery order is for the supply of 4,566,696,580 units of the medication Glycopyrrolate 1 mg/5 ml vial. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,442.46, is for the supply of GLYCOPYRROLATE INJECT, a medication, and is a firm fixed-price delivery order with an ultimate completion date of August 15, 2024. The contract has no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of glycopyrrolate 1 mg/5 ml vials. The contract has a ceiling value of $1,867.08 and a period of performance through December 9, 2024. This Delivery Order is placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,025.07 delivery order is for the supply of 4 mg/20 ml vials of the drug glycopyrrolate, a medication used to treat various conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of September 11, 2024. Amerisourcebergen, through its Corporate Office division, will provide these pharmaceutical products to support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,950.54, is for the delivery of 4565120442 - GLYCOPYRROLATE 0.2 MG/ML VIAL 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 12, 2024. This award is a delivery order under a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Glycopyrrolate 0.2 mg/ml vials (2 ml) to support military healthcare programs. The contract is a firm fixed-price, delivery order with a ceiling value of $7,599.65 and a period of performance through March 4, 2024. The award is not designated as a set-aside contract. In...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD6T6
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,254,915 units of the drug Glycopyrrolate 1 mg/5 ml vial, 5 ml, with a ceiling value of $1,495.28. It is a firm fixed-price delivery order contract with a completion date of September 9, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This specific contract award is not designated as a set-aside.

Generated 5/20/25, 2:13 PM